IDEAL-D: A rational framework for evaluating and regulating the use of medical devices

BMJ (Online)

Volumn 353, Issue , 2016, Pages

  Sedrakyan, Art ^a   Campbell, Bruce ^b   Merino, Jose G ^c   Kuntz, Richard ^d   Hirst, Allison ^e   McCulloch, Peter ^e  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE   (United Kingdom)

^c Johns Hopkins Community Physicians   (United States)

^d MEDTRONIC   (United States)

^e UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONSENSUS DEVELOPMENT; DEVICE APPROVAL; DEVICE SAFETY; HUMAN; LAW; MEDICAL DEVICE; MEDICAL DEVICE REGULATION; PRIORITY JOURNAL; RELIABILITY; EQUIPMENT DESIGN; LEGISLATION AND JURISPRUDENCE; PROCEDURES; STANDARDS; UNITED KINGDOM; UNITED STATES;

DEVICE APPROVAL; EQUIPMENT DESIGN; EQUIPMENT SAFETY; HUMANS; MEDICAL DEVICE LEGISLATION; UNITED KINGDOM; UNITED STATES;

EID: 84974676976     PISSN: 09598146     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.i2372     Document Type: Article

References (31)

1. Sedrakyan A. Metal-on-metal failures-in science, regulation, and policy. Lancet 2012;379:1174-6. doi:10.1016/S0140-6736(12)60372-9 pmid:22417409.
2. Chatterjee S, Herrmann HC, Wilensky RL, et al. Safety and procedural success of left atrial appendage exclusion with the Lariat device: a systematic review of published reports and analytic review of the FDA MAUDE database. JAMA Intern Med 2015;175:1104-9. doi:10.1001/jamainternmed.2015.1513 pmid:25938303.
3. Ardaugh BM, Graves SE, Redberg RF. The 510(k) ancestry of a metal-on-metal hip implant. N Engl J Med 2013;368:97-100. doi:10.1056/NEJMp1211581 pmid:23301729.
4. Horton R. A serious regulatory failure, with urgent implications. Lancet 2012;379:106doi: 10.1016/S0140-6736(12)60032-4.
5. Kramer DB, Xu S, Kesselheim AS. How does medical device regulation perform in the United States and the European Union? A systematic review. PLoS Med 2012;9:e1001276. doi:10.1371/journal.pmed.1001276 pmid:22912563.
6. US Food and Drug Administration. Total Product Life Cycle (TPLC) data sources and disclaimers. 2014.www.fda.gov/AboutFDA/CentersOffices/OfficeofMedicalProductsandTobacco/CDRH/CDRHTransparency/ucm207857.htm.
7. Peltzman S. An evaluation of consumer protection legislation: the 1962 drug amendments. J Polit Econ 1973;81:1049-91doi:10.1086/260107.
8. McCulloch P, Altman DG, Campbell WB, et al. Balliol Collaboration. No surgical innovation without evaluation: the IDEAL recommendations. Lancet 2009;374:1105-12. doi:10.1016/S0140-6736(09)61116-8 pmid:19782876.
9. Barkun JS, Aronson JK, Feldman LS, et al. Balliol Collaboration. Evaluation and stages of surgical innovations. Lancet 2009;374:1089-96. doi:10.1016/S0140-6736(09)61083-7 pmid:19782874.
10. Nappi F, Spadaccio C, Fouret P, et al. An experimental model of the Ross operation: development of resorbable reinforcements for pulmonary autografts. J Thorac Cardiovasc Surg 2015;149:1134-42. doi:10.1016/j.jtcvs.2014.12.056 pmid:25659190.
11. Pehrsson SK, Eriksson MJ, Lentell JC, Bowald S. Early results of a new mechanical tri-leaflet heart valve prosthesis-"tricusp": an animal study. Scand Cardiovasc J 2003;37:235-9. doi:10.1080/14017430310001681 pmid:12944213.
12. National Institutes of Health. Principles and guidelines for reporting preclinical research. 2015. www.nih.gov/about/reporting-preclinical-research.htm.
13. Hart AJ, Muirhead-Allwood S, Porter M, et al. Which factors determine the wear rate of large-diameter metal-on-metal hip replacements? Multivariate analysis of two hundred and seventy-six components. J Bone Joint Surg Am 2013;95:678-85. doi:10.2106/JBJS. J.01447 pmid:23595065.
14. Secretary of State for Transport. The civil aviation (investigation of air accidents and incidents) regulations. 1996. http://www.legislation.gov.uk/uksi/1996/2798/contents/made
15. Secretary of State for Transport. The merchant shipping (accident reporting and investigation) regulations. 2012. http://www.legislation.gov.uk/uksi/2012/1743/made
16. Winstone NE, Golby MG, Lawson LJ, Windsor CW. Biliary peritonitis: a hazard of polyvinyl chloride T-tubes. Lancet 1965;1:843-4. doi:10.1016/S0140-6736(65)91376-0 pmid: 14263542.
17. Smith AJ, Dieppe P, Vernon K, Porter M, Blom AW. National Joint Registry of England and Wales. Failure rates of stemmed metal-on-metal hip replacements: analysis of data from the National Joint Registry of England and Wales. Lancet 2012;379:1199-204. doi: 10.1016/S0140-6736(12)60353-5 pmid:22417410.
18. Lilford RJ, Braunholtz DA, Greenhalgh R, Edwards SJ. Trials and fast changing technologies: the case for tracker studies. BMJ 2000;320:43-6. doi:10.1136/bmj.320.7226. pmid:10617532.
19. Chick S, Forster M, Pertile P. A Bayesian decision-theoretic model of sequential experimentation with delayed response. 2015. www.york.ac.uk/media/economics/documents/discussionpapers/2015/1509.pdf.
20. Pennell CP, Hirst A, Sedrakyan A, McCulloch PG. Adapting the IDEAL framework and recommendations for medical device evaluation: a modified Delphi survey. Int J Surg 2016;28:141-8. doi:10.1016/j.ijsu.2016.01.082 pmid:26876957.
21. Campion TR Jr, , Johnson SB, Paxton EW, Mushlin AI, Sedrakyan A. Implementing unique device identification in electronic health record systems: organizational, workflow, and technological challenges. Med Care 2014;52:26-31. doi:10.1097/MLR. 0000000000000012 pmid:24322986.
22. Krucoff MW, Sedrakyan A, Normand SL. Bridging unmet medical device ecosystem needs with strategically coordinated registries networks. JAMA 2015;314:1691-2. doi:10.1001/jama.2015.11036 pmid:26302152.
23. Relton C, Torgerson D, O'Cathain A, Nicholl J. Rethinking pragmatic randomised controlled trials: introducing the "cohort multiple randomised controlled trial" design. BMJ 2010;340:c1066. doi:10.1136/bmj.c1066 pmid:20304934.
24. Cook JA, McCulloch P, Blazeby JM, Beard DJ, Marinac-Dabic D, Sedrakyan A. IDEAL Group. IDEAL framework for surgical innovation 3: randomised controlled trials in the assessment stage and evaluations in the long term study stage. BMJ 2013;346:f2820. doi:10.1136/bmj.f2820 pmid:23778425.
25. Grube E, Buellesfeld L, Mueller R, et al. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve revalving system. Circ Cardiovasc Interv 2008;1:167-75. doi:10.1161/CIRCINTERVENTIONS.108. 819839 pmid:20031675.
26. Leon MB, Smith CR, Mack M, et al. PARTNER Trial Investigators. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607. doi:10.1056/NEJMoa1008232 pmid:20961243.
27. Sedrakyan A, Paxton E, Graves S, Love R, Marinac-Dabic D. National and international postmarket research and surveillance implementation: achievements of the International Consortium of Orthopaedic Registries initiative. J Bone Joint Surg Am 2014;96(Suppl 1):1-6. doi:10.2106/JBJS.N.00739 pmid:25520412.
28. US Food and Drug Administration. Transcript for public workshop-bridging the IDEAL and TPLC approaches for evidence development for surgical medical devices and procedures. 2011.www.fda.gov/MedicalDevices/NewsEvents/WorkshopsConferences/ucm288553.htm.
29. US Food and Drug Administration. Investigational device exemptions (IDEs) for early feasibility medical device clinical studies, including certain first in human (FIH) studies. 2013.www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm279103.pdf.
30. McCulloch P, Cook JA, Altman DG, Heneghan C, Diener MK. IDEAL Group. IDEAL framework for surgical innovation 1: the idea and development stages. BMJ 2013;346:f3012. doi:10.1136/bmj.f3012 pmid:23778427.
31. Beyond Compliance Advisory Group. Beyond Compliance. 2015.www.beyondcompliance. org.uk/.